Skip to main content
. 2016 Aug 5;18:82. doi: 10.1186/s13058-016-0742-0

Fig. 3.

Fig. 3

Kaplan-Meier curves for recurrence-free survival (RFS) of patients with estrogen-receptor-positive tumors based on radiological complete response (black line no enhancement) and those with residual enhancement (blue line) identified on magnetic resonance imaging after neoadjuvant chemotherapy. Log-rank test p = 0.012. Numbers of patients at risk in each group are shown above the x-axis